http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9539425-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_292641d37eacac26e033ab623fa5a2d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c554ed2b4e94a49353dd62d8299beab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a15e15161991a78821c2965e9500e677
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86fab279b607071befd0d84cd624486c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc7693dae06e6b3ff39c820ec91bf5db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a722744e77c81c5f5cf415087e2ee92b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3a8eafe875bf1cb22bd6d8513f26ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38859e8d4ce18e2ee56aba8438428e7a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36017
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-361
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
filingDate 2007-10-12^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-01-10^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3ce704cfaa24ff4b2d8efba130ff80b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d733d2675ab854a58f21aa8b9fe26a6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b811af8419538342732a4b12c69e8a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d048f570d16cbaf3909c15622ed1092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1603cc1d13230e76a174f60966159316
publicationDate 2017-01-10^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9539425-B2
titleOfInvention Systems and methods for treating medical conditions by stimulation of medial thalamic region
abstract A system for treating medical conditions by neuromodulation of one or more target sites in the nervous system. In certain embodiments, at least one of the target sites is the medial thalamic region, including the intralaminar nucleus and the adjacent white and grey matter. In certain embodiments, where there is more than one target site, the other target sites is elsewhere in the nervous system, including the globus pallidus interna, subthalamic nucleus, corpus callosum, cerebellum, cerebral cortex (including the premotor cortex, motor cortex, and sensory cortex), ventral striatum, lateral thalamus, substantia nigra, and pedunculopontine nuclei. The medical conditions include movement disorders or improvement of movement function, stroke, neuropsychiatric or neuropsychologic disorders, neurodevelopmental disorders, and pain. Methods for treating medical conditions by neuromodulation of the intralaminar nuclei either alone or in combination with another target site(s) is also provided.
priorityDate 2006-10-13^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007078498-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6937903-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002151939-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6463328-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5716377-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7623927-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003097159-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6167311-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6066163-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006095088-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005010262-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300

Showing number of triples: 1 to 39 of 39.